Profound Medical
PROF
45 hedge funds and large institutions have $77.8M invested in Profound Medical in 2023 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 2 closing their positions.
700% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 2
388% more call options, than puts
Call options by funds: $78K | Put options by funds: $16K
45% more funds holding
Funds holding: 31 → 45 (+14)
11% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 9
8.31% more ownership
Funds ownership: 35.23% → 43.55% (+8.3%)
3% more capital invested
Capital invested by funds: $75.5M → $77.8M (+$2.35M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$6.14M |
| 2 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
+$1.53M |
| 3 |
BL
Bleichroeder LP
New York
|
+$1.27M |
| 4 |
KC
Kepos Capital
New York
|
+$950K |
| 5 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$682K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TIM
Timelo Investment Management
Aurora,
Ontario, Canada
|
-$583K |
| 2 |
GS
Gagnon Securities
New York
|
-$386K |
| 3 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$171K |
| 4 |
HA
Harbor Advisors
West Palm Beach,
Florida
|
-$126K |
| 5 |
RA
Royce & Associates
New York
|
-$53.2K |
PROF Hedge Fund Activity: Q4 2023 in Review
45 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Profound Medical (PROF) for Q4 2023, worth a combined $77.8M — up 3.1% from $75.5M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new PROF positions and 2 closed out — a net gain of 14 holders — while 10 added to existing stakes and 9 trimmed.
The largest buyer was AIGH Capital Management, opening a new position worth an estimated $6.14M. The largest seller was Timelo Investment Management, cutting an estimated $583K.
- 45 institutional investors held Profound Medical (PROF) as of Q4 2023, up from 31 in Q3 2023.
- Funds reported $77.8M of Profound Medical stock for Q4 2023, up 3.1% quarter-over-quarter.
- 16 funds opened new Profound Medical positions in Q4 2023 and 2 closed out, a net change of +14 holders.
- The largest Profound Medical buyer in Q4 2023 was AIGH Capital Management, an estimated $6.14M added.
- The largest Profound Medical seller in Q4 2023 was Timelo Investment Management, an estimated $583K sold.
Based on aggregated 13F filings for Q4 2023.